Brazil vs Lebanon: Death rate from cancer
Brazil
114.69 deaths per 100,000 people
in 2021
Lebanon
114.28 deaths per 100,000 people
in 2021
Brazil rank
78th
Lebanon rank
79th
Death rate from cancer over time
- Brazil
- Lebanon
How they compare
Brazil currently reports 114.69 deaths per 100,000 people against 114.28 deaths per 100,000 people in Lebanon, a difference of 0.41 deaths per 100,000 people.
The two have swapped places 4 times across 22 shared years of data; in 2000 it was Brazil ahead.
Brazil ranks 78th and Lebanon ranks 79th of 194 countries.
Brazil has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brazil | Lebanon | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 88.32 deaths per 100,000 people | 84.72 deaths per 100,000 people | 3.6 deaths per 100,000 people | Brazil |
| 2010s | 106.05 deaths per 100,000 people | 104.32 deaths per 100,000 people | 1.72 deaths per 100,000 people | Brazil |
| 2020s | 114.07 deaths per 100,000 people | 109 deaths per 100,000 people | 5.07 deaths per 100,000 people | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from cancer, Brazil or Lebanon?
- Brazil, at 114.69 deaths per 100,000 people against 114.28 deaths per 100,000 people in Lebanon as of 2021.
- What is the difference in death rate from cancer between Brazil and Lebanon?
- 0.41 deaths per 100,000 people, with Brazil ahead.
- How many years of comparable data are there for Brazil and Lebanon?
- 22 years are reported by both, from 2000 to 2021.
- How do Brazil and Lebanon rank globally for death rate from cancer?
- Brazil ranks 78th and Lebanon ranks 79th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from cancer. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from malignant neoplasms in both sexes, per 100,000 people.